$SNPS

Needham Adjusts Price Target on Synopsys to $620 From $580

Needham raised its price target on Synopsys to $620 from $580. The company's stock is currently trading at $509.99, with a 5-day change of +2.46% and a year-to-date change of +8.57%. Synopsys is also working to comply with US export rules using Chinese models.

Original reporting
Published Oct 12, 2026, 9:34 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 12, 2026, 9:56 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$SNPS
Bullish
high confidence
Mentioned
$SNPS
Relevance
7/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$SNPSBullishMed
01

Why it matters

The upgrade could prompt short‑term buying pressure and influence peer valuations.

02

Market read

Analyst target changes are a common catalyst for stock moves, especially in the tech sector.

03

What to watch

Potential supply‑chain constraints or slower AI adoption could temper upside.

Relevance 7/10Novelty 8/10Timing: pre‑market today

Background

Needham analysts issued a new price target for Synopsys, reflecting revised earnings expectations.

Company-level read

Ticker impact

$SNPSBullishHigh confidence
Context

Needham raised Synopsys' price target to $620 from $580, a new analyst recommendation.

Expected impact

likely upward pressure as investors price in the higher target

Evidence & confidence

The target increase signals improved outlook and may attract buying.

Market effects

May lift other EDA and semiconductor design software stocks.

Primarily affects US tech equities.

Limited to investors tracking semiconductor design sector.

Counterpoint

Some may view the target raise as premature given macro‑uncertainty.

Key entities

  • Synopsys

    Electronic design automation software provider.

  • Needham

    Equity research boutique that issued the price target.

Related articles

$SNPSMed

Is Synopsys Back from the Dead? EDA Leader Inks Deals With Amazon and OpenAI

Synopsys (SNPS) shares have rebounded over 30% since September, driven by a $1B+ deal with Amazon (AMZN) and a partnership with OpenAI. The Amazon deal focuses on Synopsys' IP business, with royalties expected to grow. The OpenAI collaboration aims to accelerate chip development. Synopsys raised its FY2030 revenue growth outlook to mid-teens CAGR and adjusted operating margin to 50%.

$SNPSHigh

Can Synopsys Stock Drop From Here?

Synopsys (SNPS) stock rose 28% in a month, outpacing the S&P 500, after updating growth targets and partnering with OpenAI. Q3 2026 revenue grew 8.5% for chip design tools, with total revenue at $2.477B, including $711M from Ansys. Management expects double-digit growth in Q4, driven by AI demand. Operating margin is 11.0%, below the S&P 500's 18.5%, with $10B in debt. Cash flow forecast raised to $2.8B, and $1B stock buyback announced.

$SNPSMedAI 8/10

Should $1b Amazon Deal Require Action From Synopsys (SNPS) Investors?

Synopsys (SNPS) announced a multiyear, $1B+ deal with Amazon to expand the use of its EDA, IP, and AI-based engineering tools for custom silicon. The agreement aligns with Synopsys' AI-centric roadmap and long-term financial goals. Analysts highlight potential demand visibility and capital allocation influences, while noting risks like Ansys integration and litigation. Current earnings are $1.1B, with forecasts for $2.6B by 2029, implying 13% yearly revenue growth.